Institutional & Family Asset Management, LLC Mirati Therapeutics, Inc. Transaction History

Institutional & Family Asset Management, LLC

  • $846 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021
SELL
$144.0 - $179.73 $1,152 - $1,437
-8 Closed
0 $0
Q1 2021

May 06, 2021
SELL
$158.92 - $221.61 $635 - $886
-4 Reduced 33.33%
8 $1,000
Q3 2020

Oct 30, 2020
BUY
$113.26 - $167.27 $339 - $501
3 Added 33.33%
12 $2,000
Q2 2020

Aug 14, 2020
SELL
$72.01 - $120.39 $144 - $240
-2 Reduced 18.18%
9 $1,000
Q4 2019

Feb 14, 2020
BUY
$70.76 - $128.86 $778 - $1,417
11 New
11 $1,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email